FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP) Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Financial, Nasdaq Continue Reading
Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala Business, Event, Medical, Health, Non-profit, Healthcare Continue Reading
FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP) Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI) Business, Finance, Health, Technology, Healthcare, Stocks, Artificial Intelligence, Stock Market, Financial, Nasdaq Continue Reading
DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026 Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc Business, Health, Healthcare, Biotech, Stocks, Artificial Intelligence, Stock Market, Financial, Nasdaq Continue Reading
Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029 Business, Health, Healthcare, Biotech, Stocks, Artificial Intelligence, Stock Market, Financial, Nasdaq Continue Reading
FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq Continue Reading
FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc